Bill A 612 requires New Jersey health insurers (including hospital, medical, health service corporations, and individual health insurance policies) to cover prescribed combination antiretroviral drug regimens for HIV/AIDS treatment. It mandates coverage for either single-tablet or multi-tablet regimens based on clinical effectiveness and patient adherence, as determined by healthcare providers. Insurers must process prior authorization requests within 14 days, with automatic approval if they miss the deadline. This bill directly affects people with HIV/AIDS seeking treatment and the insurers providing coverage under New Jersey law.
This bill (A 943) requires all health insurance plans sold in New Jersey - including hospital service contracts, medical service corporations, individual policies, group plans, and health maintenance organizations - to cover FDA-approved anti-obesity medications for chronic weight management. It mandates that coverage for these medications be provided "to the same extent as for any other medical condition" under the policy, meaning no additional cost-sharing or restrictions beyond standard medical coverage. The law applies to all plans issued or renewed in New Jersey after its effective date, affecting millions of residents enrolled in private health insurance. It specifically defines covered medications as those approved by the FDA for obesity treatment, not lifestyle products. The bill does not change premiums or create new funding mechanisms - it simply requires existing insurance plans to include these medications in standard coverage.
This bill requires New Jersey's Department of Health (DOH) to create standardized protocols for hospitals and licensed birthing centers to collect and report detailed, de-identified data on maternity care. The data must cover specific metrics like maternal health conditions (e.g., hypertension, hemorrhage), delivery methods (e.g., induction timing, cesarean rates), and infant outcomes (e.g., birth weight, complications). The DOH will annually evaluate this data to set statewide benchmarks, identify quality improvement opportunities, and compare hospital performance. Results and recommendations must be reported to the Governor and Legislature yearly, aiming to enhance maternal and infant health outcomes through data-driven care.
This bill requires New Jersey hospitals to provide mental health evaluations to patients treated for drug overdoses before discharge. It mandates that all health insurance plans - including hospital service contracts, medical service contracts, and individual/group policies - cover these evaluations at the same level as other medical treatments. The law directly affects hospitals, insurers, and patients recovering from drug overdoses in New Jersey. It ensures coverage for these evaluations without additional cost-sharing, applying to all relevant insurance contracts issued or renewed in the state.
This bill sets a 150% cap on hospital charges for laboratory services, limiting what hospitals can bill patients to 150% of the federal Medicare payment rate for those services. It applies to patients who do not qualify for the existing 115% cap under P.L.2008, c.60 (which covers uninsured patients with family income under 500% of the federal poverty level). Hospitals must adhere to this 150% limit for all laboratory services provided to qualifying patients, excluding those already covered by the lower 115% threshold. The policy change specifically targets lab service billing and does not affect other hospital charges or services.
This bill requires New Jersey colleges and universities to maintain a supply of naloxone nasal spray (for opioid overdose emergencies) in secure, accessible campus locations and develop a campus policy for its emergency use. It directly affects institutions of higher education, licensed campus medical staff, and designated campus personnel like resident assistants who may administer naloxone after required training. Key provisions include mandating hospital transport for overdose victims after naloxone use, permitting trained non-medical staff to administer the drug in good faith, and providing liability protection for those acting in compliance with the law. The policy must be developed with guidance from the state’s higher education and human services departments.
This bill establishes two new entities in New Jersey: the Office of Healthcare Affordability and Transparency (within the Department of Health) and the Health Care Cost Containment and Price Transparency Commission. It requires hospitals, health insurers, and other healthcare providers to publicly report detailed pricing data for services like inpatient care, emergency visits, and physician services. The Commission will set annual benchmarks for healthcare cost growth and hospital pricing, monitor entities exceeding these benchmarks, and may impose public transparency requirements or civil penalties for noncompliance. These provisions directly affect all New Jersey hospitals, health insurers, and healthcare providers by mandating transparency in pricing and cost reporting to promote affordability.
This bill requires all health insurance plans in New Jersey to cover pelvic floor physical therapy for one year after childbirth. It applies to hospital service, medical service, health service, individual, group, and health benefits plans. The coverage must be provided at the same level as for other medical conditions, meaning no higher out-of-pocket costs or restrictions than standard medical care. This directly affects women who have given birth and are covered by these insurance plans during the postpartum period.
This bill establishes a pilot program in New Jersey's Department of Human Services to connect emergency department patients with behavioral health needs - such as mild mental health issues, emotional disturbances, or substance use disorders that don't require inpatient care - to coordinated community treatment. Participating hospitals (two per Regional Health Hub) must refer these patients to available services, while Regional Health Hubs will support hospitals in developing protocols for timely referrals, follow-up, transportation, and appointment scheduling. The program requires Medicaid and NJ FamilyCare to cover these services, with the state seeking federal funding to support implementation. It directly affects emergency patients with non-emergency behavioral health needs and hospitals participating in the pilot.
This bill requires all health insurers operating in New Jersey - including hospital service corporations, medical service corporations, health service corporations, individual health insurance policies, group health plans, and individual health benefits plans - to cover the diagnosis, evaluation, and treatment of lymphedema when deemed medically necessary by a patient’s physician. It applies to all such insurance contracts delivered, issued, or renewed in New Jersey after the bill’s effective date, mandating coverage at the same level and cost-sharing (like deductibles and coinsurance) as for other similar medical services. The bill directly affects patients with lymphedema and insurers by ensuring this specific condition is treated as a standard covered service under existing policies. It does not alter overall coverage limits or introduce new funding, but expands mandatory benefits to include lymphedema care.
